Evaluation of the evolution of patients with vitreous hemorrhage caused by proliferative diabetic retinopathy subjected to intravitreal injection of antivascular endothelial growth factor (bevacizumab)

计划入组 60 人

IVB for Post-vitrectomy Hemorrhage in Diabetic Eyes

计划入组 18 人 · 首次发布于 2024 年 8 月 19 日

Adjuvant Intravitreal Bevacizumab in Pars Plana Vitrectomy for Diabetic Vitreous Hemorrhage

计划入组 2 人 · 首次发布于 2010 年 6 月 28 日

Pi (hemorrhage)

hemorrhage therapeutics (Biolotus Biotech)

Ocriplasmin(Jetrea)

Retina-Vitreous Assoc Inc

United States

RETINA-VITREOUS ASSOCIATES, INC.

United States

MACULA RETINA VITREOUS RESEARCH INSTITUTE

United States

AAO 2024: 3D-Printed Glasses, ANX007 for Geographic Atrophy, and Cataract Surgery Risks Highlighted

Merck's trispecific remigromig matches ranibizumab in phase 2b/3 diabetic macular edema trial

Clinical Trial to Evaluate Dexamethasone Implant with Vitrectomy for Proliferative Diabetic Retinopathy